Our study emphasizes that APOE-ε4 is associated with the risk of both AD+LB– pathology (OR = 4.22, P = 1.4 × 10−69) and AD+LB+ co-pathology (OR = 4.24, P = 1. The gene discussed is APOE; the disease is Alzheimer disease.